The Latest Breaking News on Pharma

ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.

Kauffman had built Marion Labs into a solid pharmaceutical business. To reach the next level, he knew he needed to take risks.

In a post-COVID world, society is branching away from pharmaceutical medicine and seeking support that may be less likely to cause side effects.

Intra-Cellular stock: Shares rocketed more than 23% Tuesday, sending them past their latest buy point on the stock market today.

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

Neumora said Monday the FDA put its schizophrenia drug on hold after rabbits experienced convulsions, and the biotech stock plunged.

Nvidia, which bucked the S&P 500 downdraft last week, leads this weekend's watch list of five stocks near buy points.

Despite rebellion, approval of £18.7m package opens door to likelihood of US-style executive pay elsewhere

Regeneron stock toppled Thursday after the DOJ filed a lawsuit saying the drugmaker fraudulently inflated the prices of its drug, Eylea.

Friday Plans has a stellar 4.3-star rating on Trustpilot, with 40,000+ subscribers praising the convenience, speed, affordability, and effectiveness of their Viagra and Cialis products.

Third of voters reject Pascal Soriot’s deal but some say it is deserved as he had been ‘massively underpaid’